Search

Search Constraints

You searched for: Author/Creator Owen, Roger

Search Results

1. Biologically defined risk groups can be used to define the impact of thalidomide maintenance therapy in newly diagnosed multiple myeloma. Issue 9 (September 2013)

3. Correlation between DNA damage responses of skin to a test dose of radiation and late adverse effects of earlier breast radiotherapy. Issue 2 (May 2016)

4. COVID‐19 and myeloma clinical research – experience from the CARDAMON clinical trial. (21st November 2020)

5. Diagnosis and management of Waldenström macroglobulinaemia—A British Society for Haematology guideline. (12th January 2022)

6. Early relapse after high‐dose melphalan autologous stem cell transplant predicts inferior survival and is associated with high disease burden and genetically high‐risk disease in multiple myeloma. (10th June 2020)

8. Frailty-adjusted therapy in Transplant Non-Eligible patients with newly diagnosed Multiple Myeloma (FiTNEss (UK-MRA Myeloma XIV Trial)): a study protocol for a randomised phase III trial. Issue 6 (2nd June 2022)

10. Innovation in Citizen Science – Perspectives on Science-Policy Advances. (27th April 2018)